+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ophthalmic Corticosteroid Market - Global Forecast 2025-2030- Product Image
Ophthalmic Corticosteroid Market - Global Forecast 2025-2030- Product Image
Sale

Ophthalmic Corticosteroid Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ophthalmic corticosteroid therapeutics market is undergoing rapid transformation, fueled by technological advances and a shift toward patient-centric care. Senior executives are navigating a dynamic environment shaped by complex regulatory changes, supply chain adjustments, and evolving therapeutic priorities.

Ophthalmic Corticosteroid Therapeutics Market Snapshot

This market addresses critical needs in ocular inflammation management, encompassing postoperative care, uveitis, and dry eye syndromes. Stakeholders are leveraging innovative drug delivery approaches and responding to stricter regulatory scrutiny, while balancing efficacy and patient adherence. Growth across diverse segments highlights competitive differentiation through advanced formulations and supply chain resilience, positioning companies to meet rising global demand.

Scope & Segmentation

  • Product Types: Dexamethasone, Fluorometholone, Loteprednol, Prednisolone
  • Route of Administration: Eye Drops, Gels, Injectables, Ointments
  • Distribution Channels: Hospital Pharmacies (Government Hospitals, Private Hospitals), Online Pharmacies (Branded Platforms, E-Commerce Platforms), Retail Pharmacies (Chain Pharmacies, Independent Pharmacies)
  • Indications: Allergic Conjunctivitis, Dry Eye, Postoperative Inflammation, Uveitis (Anterior, Intermediate, Posterior)
  • End Users: Clinics (Multi Specialty, Ophthalmology), Diagnostic Centers (Hospital-Based, Independent), Hospitals (Government, Private)
  • Geographies Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Profiled: Alcon Inc., Bausch + Lomb Corporation, Allergan PLC, Santen Pharmaceutical Co., Ltd., Novartis AG, Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Viatris Inc., Apotex Inc.
  • Innovative Technologies: Microparticle encapsulation, sustained-release implants, nanotechnology-enabled carriers, advanced gel formulations, telehealth integration, remote monitoring applications

Key Takeaways for Decision Makers

  • Recent clinical demand has accelerated the adoption of advanced drug delivery systems, such as sustained-release and nanocarrier platforms, improving treatment adherence and expanding precision dosing options.
  • Market activity is increasingly influenced by the push for patient-centric models, driving formulary updates and the use of noninvasive, procedure-driven therapies.
  • Regulatory changes continue to impact development pipelines, with manufacturers refining delivery technologies and prioritizing safety profile differentiation.
  • Competitive strategies now leverage alliances between pharmaceutical and device innovators, supported by robust evidence generation to stand out in an innovation-focused landscape.
  • Distinct regional dynamics shape adoption and access, with mature markets emphasizing clinical rigor and emerging regions focusing on affordability, scalability, and local manufacturing expansion.
  • Segmentation by product, indication, and end user is enabling tailored strategies that align commercial priorities with evolving healthcare delivery models.

Tariff Impact on Ophthalmic Corticosteroid Supply Chains

The introduction of United States tariff measures in 2025 has added complexity for manufacturers and supply chain stakeholders. Increased import duties on active ingredients and packaging have driven up costs, prompting a move toward nearshoring and diversified supplier partnerships. Distribution agreements are shifting to incorporate flexible sourcing and risk-sharing models, placing a premium on supply chain agility and policy monitoring to safeguard market continuity.

Research Methodology & Data Sources

This report applies a proven methodology combining primary interviews with industry experts, comprehensive secondary research, and data triangulation. Input from ophthalmologists, procurement leaders, and regulatory authorities informed assessment of product utilization, technological trends, and access barriers. Sources include peer-reviewed literature, clinical data repositories, and regulatory filings; all findings are validated by a panel of market specialists.

Why This Report Matters

  • Enables strategic planning by offering a clear view of evolving market segments, innovation trends, and regulatory drivers.
  • Delivers targeted insights for optimizing supply chain resilience, product pipeline prioritization, and regional go-to-market strategies.
  • Supports executive decision-making with actionable recommendations on partnership building, technology adoption, and patient engagement initiatives.

Conclusion

The ophthalmic corticosteroid therapeutics landscape is characterized by active innovation, shifting care models, and evolving regulatory dynamics. Informed action on partnership formation, technology deployment, and agile supply strategies will be essential for market leadership and sustainable growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of preservative-free ophthalmic corticosteroid formulations to reduce ocular surface toxicity
5.2. Advances in nanoparticle-based delivery systems enhancing corticosteroid penetration in ocular tissues
5.3. Emergence of biosimilar ophthalmic corticosteroids intensifying price competition in key markets
5.4. Impact of teleophthalmology adoption on prescribing patterns for retinal and anterior segment inflammation
5.5. Regulatory evolutions accelerating approval pathways for novel ophthalmic corticosteroid implants and injectables
5.6. Integration of combination therapies pairing corticosteroids with anti-inflammatory agents in diabetic macular edema management
5.7. Strategies to improve patient adherence through sustained-release corticosteroid implants in chronic uveitis
5.8. Rapid expansion of ophthalmic corticosteroid demand in emerging markets driven by rising diabetes-related ocular complications
5.9. Payer-driven cost containment measures and reimbursement reforms affecting corticosteroid eye drop utilization
5.10. Collaborations between pharma and device companies to develop drug-eluting contact lenses for corticosteroid delivery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ophthalmic Corticosteroid Market, by Product Type
8.1. Introduction
8.2. Dexamethasone
8.3. Fluorometholone
8.4. Loteprednol
8.5. Prednisolone
9. Ophthalmic Corticosteroid Market, by Route of Administration
9.1. Introduction
9.2. Eye Drops
9.3. Gels
9.4. Injectables
9.5. Ointments
10. Ophthalmic Corticosteroid Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Government Hospitals
10.2.2. Private Hospitals
10.3. Online Pharmacies
10.3.1. Branded Platforms
10.3.2. E Commerce Platforms
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Ophthalmic Corticosteroid Market, by Indication
11.1. Introduction
11.2. Allergic Conjunctivitis
11.3. Dry Eye
11.4. Postoperative Inflammation
11.5. Uveitis
11.5.1. Anterior
11.5.2. Intermediate
11.5.3. Posterior
12. Ophthalmic Corticosteroid Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Multi Specialty Clinics
12.2.2. Ophthalmology Clinics
12.3. Diagnostic Centers
12.3.1. Hospital Based
12.3.2. Independent
12.4. Hospitals
12.4.1. Government
12.4.2. Private
13. Americas Ophthalmic Corticosteroid Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Ophthalmic Corticosteroid Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Ophthalmic Corticosteroid Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alcon Inc.
16.3.2. Bausch + Lomb Corporation
16.3.3. Allergan PLC
16.3.4. Santen Pharmaceutical Co., Ltd.
16.3.5. Novartis AG
16.3.6. Pfizer Inc.
16.3.7. Sandoz International GmbH
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Viatris Inc.
16.3.10. Apotex Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. OPHTHALMIC CORTICOSTEROID MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. OPHTHALMIC CORTICOSTEROID MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. OPHTHALMIC CORTICOSTEROID MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. OPHTHALMIC CORTICOSTEROID MARKET: RESEARCHAI
FIGURE 26. OPHTHALMIC CORTICOSTEROID MARKET: RESEARCHSTATISTICS
FIGURE 27. OPHTHALMIC CORTICOSTEROID MARKET: RESEARCHCONTACTS
FIGURE 28. OPHTHALMIC CORTICOSTEROID MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OPHTHALMIC CORTICOSTEROID MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY FLUOROMETHOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY FLUOROMETHOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY LOTEPREDNOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY LOTEPREDNOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY EYE DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY BRANDED PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY BRANDED PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DRY EYE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DRY EYE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY POSTOPERATIVE INFLAMMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY POSTOPERATIVE INFLAMMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ANTERIOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ANTERIOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INTERMEDIATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INTERMEDIATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY POSTERIOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY POSTERIOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 160. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 161. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 172. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 173. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. CANADA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 308. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 309. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY OPHTHALMIC CORTICOSTEROID MARKET SIZE, BY UVEITIS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY OPHTHALMIC CORTICOSTEROID

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ophthalmic Corticosteroid market report include:
  • Alcon Inc.
  • Bausch + Lomb Corporation
  • Allergan PLC
  • Santen Pharmaceutical Co., Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Apotex Inc.

Related Topics

Related Reports

Age-Related Macular Degeneration: Market Share, and Growth Analysis by Product Type (Anti-VEGF Drugs, Photodynamic Therapy, Corticosteroids), Application, End User, Technology - Product Image

Age-Related Macular Degeneration: Market Share, and Growth Analysis by Product Type (Anti-VEGF Drugs, Photodynamic Therapy, Corticosteroids), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Adrenal Corticosteroid Inhibitors Market - Global Forecast 2025-2030 - Product Image

Adrenal Corticosteroid Inhibitors Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Nasal Corticosteroid Sprays Market - Global Forecast 2025-2030 - Product Image

Nasal Corticosteroid Sprays Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Nasal Corticosteroids - Global Strategic Business Report - Product Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • 469 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.